• Genova was jointly founded by the entrepreneurship management team, overseas venture capital fund BVCF and Changzhou life and health industry development fund; During the same period,Genova completed round A financing of US $30 million.

• The filing of phase I project was completed, the foundation of phase II project industrial base was laid, and the construction of R & D center was started.

• The R & D center was completed and put into use; Genova won the government's award of RMB 30 million for settlement.

• Completed round B financing of USD 50 million; The construction of phase I project has been basically completed.

• After the QP audit, the EU clinical trial drug production of insulin series products was carried out.

• Complete the production of EU clinical trial drugs, submit the application for European clinical trial and carry out; Obtained the "drug production enterprise license" issued by Jiangsu food and Drug Administration and was selected as the "potential Unicorn enterprise" in Jiangsu Province.

• Complete the acquisition of Mitsubishi tanbian Hokkaido branch in Japan, which has the world's largest single fermentation tank production line with a production capacity of 320 tons; Complete round B + financing of USD 30 million.